<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04496934</url>
  </required_header>
  <id_info>
    <org_study_id>2013/00731</org_study_id>
    <nct_id>NCT04496934</nct_id>
  </id_info>
  <brief_title>Physical Activity as Adjunct Treatment for Opioid Substitution Therapy</brief_title>
  <official_title>Physical Activity as Adjunct Treatment for Opioid Substitution Therapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Haukeland University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Helse Stavanger HF</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kristiania University College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Bergen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Western Norway University of Applied Sciences</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Solli Distriktspsykiatriske Senter</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Haukeland University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In terms of research, it is documented that exercise has a positive effect on mental&#xD;
      disorders. Studies have shown positive correlations between physical and mental health, also&#xD;
      among substance users. Such a study has never been performed on patients in opioid&#xD;
      substitution therapy (OST). Documentation on the physical health of patients and the effect&#xD;
      of exercise is very limited. Treatment of substance users is a research area with&#xD;
      insufficient knowledge about certain treatment effects. It is important that a treatment can&#xD;
      both support and promote the user's own resources and efforts to change their habits of&#xD;
      substance use.&#xD;
&#xD;
      The objective of this project is to examine the effect of exercise for OST patients, measured&#xD;
      in relation to cognitive function and physical form. The target group consists of OST&#xD;
      patients from 18 years of age and up, of both sexes, and on stable medication. At least 60&#xD;
      participants should complete the project, which is designed as a controlled randomized study&#xD;
      (RCT). Participants in the intervention group start to exercise immediately after baseline&#xD;
      testing. Participants in the control group are on a waiting list and will start to exercise&#xD;
      after twelve weeks. Both groups undergo testing at baseline, after three, six and 12 months.&#xD;
      Testing consists of two parts: A battery of cognitive and psychosocial assessments and an&#xD;
      assessment of physical variables.&#xD;
&#xD;
      The research questions of this project are important in a public health perspective.&#xD;
      Generated knowledge can be quickly applied to local treatment institutions in Norway.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 30, 2018</start_date>
  <completion_date type="Actual">January 31, 2020</completion_date>
  <primary_completion_date type="Actual">January 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Height and weight</measure>
    <time_frame>12 weeks</time_frame>
    <description>Weight and height will be combined to report BMI in kg/m^2</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Endurance</measure>
    <time_frame>12 weeks</time_frame>
    <description>Ventilatory threshold/VO2max (endurance test on treadmill)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Strength</measure>
    <time_frame>12 weeks</time_frame>
    <description>Push-ups (maximal test where the participants perform a maximum number of correct push-ups)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Balance</measure>
    <time_frame>12 weeks</time_frame>
    <description>Stork Balance Test (timed test where the goal is to keep one's balance as long as possible)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Alcohol use</measure>
    <time_frame>12 weeks</time_frame>
    <description>AUDIT-E</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Drug use</measure>
    <time_frame>12 weeks</time_frame>
    <description>DUDIT-E</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Executive functions</measure>
    <time_frame>12 weeks</time_frame>
    <description>Behavior Rating Inventory of Executive Function - Adult Version (BRIEF-A)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction with life</measure>
    <time_frame>12 weeks</time_frame>
    <description>Satisfaction With Life Scale (SWLS)&#xD;
Values/scores:&#xD;
7 - Strongly agree&#xD;
6 - Agree&#xD;
5 - Slightly agree&#xD;
4 - Neither agree nor disagree&#xD;
3 - Slightly disagree&#xD;
2 - Disagree&#xD;
1 - Strongly disagree&#xD;
Results (sum of scores/values):&#xD;
31 - 35 Extremely satisfied 26 - 30 Satisfied 21 - 25 Slightly satisfied 20 Neutral 15 - 19 Slightly dissatisfied 10 - 14 Dissatisfied 5 - 9 Extremely dissatisfied The higher the score the better the outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sleep quality</measure>
    <time_frame>12 weeks</time_frame>
    <description>Pittsburgh Sleep Quality Index (PSQI)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Attention</measure>
    <time_frame>12 weeks</time_frame>
    <description>Connors Continuous Performance Test (CPT 3)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">17</enrollment>
  <condition>Opioid-use Disorder</condition>
  <condition>Substance Use Disorders</condition>
  <condition>Opioid Dependence</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Exercise intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The control group is a waiting list group. The participants will receive exercise intervention after twelve weeks of treatment as usual.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>Exercise of choice with a training contact: 3 hrs/week, total of 12 weeks.</description>
    <arm_group_label>Control</arm_group_label>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Participants must sign a informed consent form&#xD;
&#xD;
          -  Must be participating in an opioid substitution program&#xD;
&#xD;
          -  Must be on a steady fixed dose of medication&#xD;
&#xD;
          -  Must be at least 18 years of age&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Being in opioid substitution program for less than three months&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Asgeir Mamen, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Kristiania University College</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Haukeland University Hospital</name>
      <address>
        <city>Bergen</city>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>October 25, 2018</study_first_submitted>
  <study_first_submitted_qc>July 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 4, 2020</study_first_posted>
  <last_update_submitted>August 11, 2020</last_update_submitted>
  <last_update_submitted_qc>August 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Substance-Related Disorders</mesh_term>
    <mesh_term>Opioid-Related Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>January 11, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/34/NCT04496934/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>January 11, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/34/NCT04496934/ICF_001.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

